AI blood assay detects liver cancer across diverse international populations

Researchers astatine the Johns Hopkins Kimmel Cancer Center validated an artificial quality (AI)-powered humor trial that accurately detected liver crab successful radical from 2 geographically and biologically chiseled populations and uncovered the underlying biologic signals that marque the trial effective.